The value of periportal hyperintensity sign from gadobenate dimeglumine-enhanced hepatobiliary phase MRI for predicting clinical outcomes in patients with decompensated cirrhosis

The value of periportal hyperintensity sign from gadobenate dimeglumine-enhanced hepatobiliary phase MRI for predicting clinical outcomes in patients with decompensated cirrhosis

Abstract Objectives To determine the value of periportal hyperintensity sign from gadobenate dimeglumine (Gd-BOPTA)-enhanced hepatobiliary phase (HBP) magnetic resonance imaging (MRI) for predicting clinical outcomes in patients with decompensated cirrhosis. Methods A total of 199 cirrhotic patients...

Full description

Bibliographic Details
Main Authors: Lanqing Cong, Yan Deng, Shuo Cai, Gongzheng Wang, Xinya Zhao, Jingzhen He, Songbo Zhao, Li Wang
Format: Article
Language:English
Published: SpringerOpen 2024-02-01
Series:Insights into Imaging
Subjects:
Gadobenate dimeglumine, Periportal hyperintensity sign, Liver cirrhosis, Magnetic resonance imaging, Clinical outcomes
Online Access:https://doi.org/10.1186/s13244-024-01629-4

Internet

https://doi.org/10.1186/s13244-024-01629-4

Similar Items